Roll-over Study to Allow Continued Access to Ribociclib

Condition:   Metastatic Breast Cancer Interventions:   Drug: Ribociclib;   Drug: Letrozole;   Drug: Anastrozole;   Drug: Goserelin;   Drug: Tamoxifen;   Drug: Fulvestrant Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials